These clinical entities share pathological and immune features with idiopathic pulmonary fibrosis (IPF), a paradigmatic chronic progressive fibrosing disease whose chemokine biomarkers include CCL18 and CXCL13 (80–84). This evidence concerns the gene CXCL13 and pulmonary fibrosis.